PUNE, India, November 17, 2015 /PRNewswire/ --
As more participants enter contrast media / contrast agent market in China, number of imaging equipment is increasing in China along with usage volume of contrast media, which is on the rapid growing trend.
Complete report on china contrast media (contrast agent) market spread across 65 pages, profiling 5 major contrast media manufacturing enterprises is now available at is now available at http://www.rnrmarketresearch.com/research-and-development-forecast-of-china-contrast-media-contrast-agent-market-2015-2020-market-report.html.
The Contrast Media Manufacturing Enterprises in China are Yangtze River Pharmaceutical Group, BEILU Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., China Resources Double-crane Pharmaceutical Co., Ltd. and Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
The main raw materials of contrast media in the upstream market are bulk drugs such as iohexol and barium sulfate. Iohexol segment market is small, suppliers and purchasers are relatively concentrated in this market and purchasing prices are settled by manufacturers. The main iohexol suppliers are the three, so raw material purchase of manufacturing enterprises is relatively concentrated. If bulk drug suppliers increase prices, manufacturing enterprises have difficulties to change other suppliers, so they may face risks relating to rising production cost. Therefore upstream suppliers have strong bargaining power in contrast media industry.
The downstream markets of contrast media industry mainly are drug dealers or hospitals. The purchasing prices are settled by the two parties because of quantity buying or long-term buying, or customers can purchase by invitation to bid, at this time customers have relatively stronger bargaining power.
Currently domestic enterprises with large market scale in contrast media field are few, foreign capital enterprises occupy more than half of Chinese market and are in a leading position; while domestic enterprises represented by Yangtze River Pharmaceutical, Jiangsu Hengrui Medicine and BEILU Pharmaceutical realized the rapid expansion and increased market shares by virtue of cost performance advantage and local academic marketing.
According to the procurement of contrast media from sample hospitals in 16 cities, the CT contrast media with market shares ranking top 4 in China are iohexol, iopromide, ioversol and iodixanol successively, with market shares of 20.23%, 20.21%, 19.32% and 9.32% respectively. Order a copy of Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2015-2020 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=428430.
According to the sales of enterprises, there are no big differences between Chinese contrast media market and international market. Iohexol produced by Shanghai Amersham Health (a subsidiary of GE Healthcare) and iodine by Schering Pharmaceutical Ltd.(Guangdong) occupy the most market shares, and iohexol by Yangtze River Pharmaceutical, iopamidol by Shanghai Bracco Sine Pharmaceutical Corp. Ltd and ioversol by Jiangsu Hengrui Medicine are placed on the second group, and iohexol produced by GUERBET LABS (a French company) and BEILU Pharmaceutical and meglumine diatrizoate by Shanghai Xudong Haipu Pharmaceutical Co., Ltd. rank third group. Their market shares of main products and proportion of their products in sampled hospitals are listed in the following:
As for domestic MRI contrast media market, gadopentetate dimegulmine still plays a leading role. Schering Pharmaceutical (Guangdong) accounts for less than 40% of market shares, BEILU Pharmaceutical follows behind it after imitating the same products of Schering. GE Healthcare falls behind Schering Pharmaceutical in domestic MRI market, with only about 10% of market shares, and GE is surpassed by BEILU Pharmaceutical, Consun Pharmaceutical Group Limited follows behind GE Healthcare.
Another report analysed by other team of analyst is Global Contrast Media/Contrast Agents Market 2015-2019 forecast global contrast media/contrast agent market to grow at a CAGR of 6.95% over the period 2014 - 2019. The global contrast media/contrast agent market can be segmented into three based on type: iodinated, gadolinium-based and barium-based contrast media/contrast agent.
The report analysis the key players in the global contrast media/contrast agents market are Bayer Healthcare, Bracco Diagnostic, Covidien, GE Healthcare and Guerbet Group
Other prominent vendors in the contrast media/contrast agents market are also analysed - Access the complete report at http://www.rnrmarketresearch.com/global-contrast-mediacontrast-agents-market-2015-2019-market-report.html.
Explore more reports on biotechnology market at http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
SOURCE RnR Market Research